Cargando…
Fecal S100A12 in Healthy Infants and Children
Background and Aims. Fecal S100A12 is shown to be a useful noninvasive marker of gut inflammation. However, the studies to date have not characterised the patterns of expression in healthy young children. This study aimed to determine S100A12 levels in infants and children without symptoms of underl...
Autores principales: | Day, A. S., Ehn, M., Gearry, R. B., Lemberg, D. A., Leach, S. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3787569/ https://www.ncbi.nlm.nih.gov/pubmed/24167377 http://dx.doi.org/10.1155/2013/873582 |
Ejemplares similares
-
Inflammatory Bowel Disease in Australasian Children and Adolescents
por: Day, A. S., et al.
Publicado: (2014) -
The Role of S100A12 as a Systemic Marker of Inflammation
por: Meijer, B., et al.
Publicado: (2012) -
The Value of Fecal Markers in Predicting Relapse in Inflammatory Bowel Diseases
por: Galgut, Bianca J., et al.
Publicado: (2018) -
Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
por: Duvoisin, Gilles, et al.
Publicado: (2017) -
Differences in Gut Microbiome Profile between Healthy Children and Children with Inflammatory Bowel Disease and/or Autoimmune Liver Disease: A Case-Control Study
por: Lopez, Robert N., et al.
Publicado: (2023)